Astrotech (NASDAQ:ASTC) Downgraded by Wall Street Zen to Strong Sell

Posted by Brian Himes on Jul 21st, 2026

Wall Street Zen lowered shares of Astrotech (NASDAQ:ASTC – Free Report) from a sell rating to a strong sell rating in a report published on Monday.

Separately, Weiss Ratings upgraded shares of Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on ASTC

Astrotech Stock Performance

Shares of ASTC opened at $7.60 on Monday. The stock has a fifty day moving average price of $14.33 and a two-hundred day moving average price of $7.09. Astrotech has a 52-week low of $1.91 and a 52-week high of $68.85. The company has a market cap of $13.68 million, a price-to-earnings ratio of -0.90 and a beta of 4.77.

Astrotech (NASDAQ:ASTC – Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. The business had revenue of $0.34 million during the quarter. Astrotech had a negative return on equity of 81.85% and a negative net margin of 1,397.82%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Susquehanna International Group LLP bought a new stake in shares of Astrotech during the third quarter worth $66,000. DRW Securities LLC lifted its stake in shares of Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after acquiring an additional 19,747 shares during the period. Finally, J. Safra Sarasin Holding AG bought a new position in Astrotech in the first quarter valued at about $140,000. Institutional investors and hedge funds own 24.35% of the company’s stock.

About Astrotech

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.